News from the FDA/CDC
News from the FDA/CDC
Duloxetine Bottles Recalled by FDA Because of Potential Carcinogen
The nationwide recall of more than 7000 bottles of duloxetine delayed-release capsules is due to unacceptable levels of a potential carcinogen.
News from the FDA/CDC
FDA Approves Nonstimulant Liquid Onyda XR for ADHD
The once-daily extended-release oral suspension, with nighttime dosing, can be used alone or as an adjunctive therapy to FDA-approved stimulant...
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.
News from the FDA/CDC
FDA Recommends DEA Move Cannabis From Schedule I to III
The FDA said in its report that cannabis is a low-risk threat to public health.
News from the FDA/CDC
High school students using less tobacco, vape products, CDC report shows
“Sustained efforts to prevent initiation of tobacco product use among young persons and strategies to help young tobacco users quit are critical...
Latest News
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
The cosmetic products include makeup products, nail polishes, shaving creams, other grooming products, perfumes, face and body cleansers, hair...
News from the FDA/CDC
FDA approves first pill for postpartum depression
Zuranolone is a neuroactive steroid that acts on GABAA receptors in the brain responsible for regulating mood, arousal, behavior, and cognition....
FDA/CDC
FDA panel unanimously endorses lecanemab for Alzheimer’s
An intravenous infusion targeting amyloid-beta, lecanemab received accelerated FDA approved earlier in 2023 for the treatment of early Alzheimer’s...
News from the FDA/CDC
FDA approves buprenorphine injection for opioid use disorder
Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.
News from the FDA/CDC
Overdose deaths mark another record year, but experts hopeful
“But these numbers are still extraordinarily high. We shouldn’t suggest the crisis is in any way over.”
News from the FDA/CDC
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.